Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)

This study has been completed.

Study NCT00590044 Information provided by Emory University

First Received: December 28, 2007 Last Updated: May 18, 2009 History of Changes

Study Type:	Interventional
Study Design:	Randomized, Open Label, Parallel Assignment
Condition:	Diabetic Ketoacidosis
Interventions:	Drug: insulin glargine+ glulisine Drug: NPH + Regular insulin

Participant Flow

Recruitment Details

Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details

Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups

	Description
1	Daily insulin glargine (Lantus) + glulisine (Apidra) before meals
2	Split-mixed NPH + Regular insulin twice daily

Participant Flow: Overall Study

Baseline Characteristics

Reporting Groups

	Description
1	Daily insulin glargine (Lantus) + glulisine (Apidra) before meals
2	Split-mixed NPH + Regular insulin twice daily

Baseline Measures

	1	2	Total
Number of Participants [units: participants]	38	36	74
Age [units: participants]
<=18 years	0	0	0
Between 18 and 65 years	38	36	74
>=65 years	0	0	0
Age [units: years] Mean ± Standard Deviation	39 ± 12	38 ± 12	38.5 ± 12
Gender [units: participants]
Female	14	12	26
Male	24	24	48
Region of Enrollment [units: participants]
United States	38	36	74